Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Am J Kidney Dis. 2019 Sep 20;75(2):187–194. doi: 10.1053/j.ajkd.2019.06.011

Table 2.

Pre-Angiography Plasma and Urine Biomarker Levels by MAKE-D Status

Plasma Biomarker Urine Biomarker
Median [IQR], pg/mL P Median [IQR, pg/mL P
MAKE-D No MAKE-D Unadj Adj* MAKE-D No MAKE-D Unadj Adj*
KIM-1 504 (306, 948) 321 (189, 585) <0.001 0.04 1804 (961,3558) 1392 (720, 2743) 0.06 0.2
NGAL 259 (209, 420) 228 (173, 296) 0.001 0.04 37 (16, 97) 23 (11, 49) 0.009 0.09
IL-18 332 (238, 446) 318 (246, 408) 0.5 0.9 33 (16, 54) 21 (12, 37) 0.003 0.01
MCP-1 229 (167, 280) 217 (181,270) 0.9 0.9 289 (159, 565) 205 (118, 363) 0.01 0.1
UMOD 59 (41,81) 71 (51, 97) 0.006 0.01 2300 (1462, 3642) 2484 (1554, 3944) 0.5 0.9
YKL-40 141987 (98750, 284819) 91371 (53545, 174700) <0.001 0.001 902 (272, 4474) 394 (127, 1184) <0.001 0.02

Urine creatinine-corrected results in Table S1

*

Adjusted for Urinary Albumin-Creatinine Ratio and baseline eGFR

Adj, adjusted; unadj, unadjusted; KIM-1 [kidney injury marker 1], NGAL [neutrophil gelatinase-associated lipocalin], IL-18 [interleukin 18], MCP-1 [monocyte chemoattractant protein 1], UMOD [uromodulin], and YKL-40 [chitinase-3-like protein 1]; MAKE-D, major adverse kidney events and death.